National News

New Regulatory Regime for 8 Medical Items under Drugs and Cosmetics Act

Transition time of 6 months allowed for ensuring supply chain continuity and access while implementing their regulatory order under Medical Devices Rules (2017)

Posted On: 18 APR 2021 7:05PM by PIB Delhi

Adopting a proactive and sensitive approach to address the needs of the Indian Industry, the Union Ministry of Health & Family Welfare has taken a significant decision for ensuring continued access of eight regulated medical devices today.

The Ministry had earlier notified the following medical items to be regulated under the Drugs and Cosmetics Act which was to come into effect from 1st April, 2021 (as per S.O. 775(E) dated 08th February, 2019 under Medical Devices Rules 2017):

  1. All Implantable Medical Devices;
  2. CT scan equipment;
  3. MRI equipment;
  4. Defibrillators;
  5. PET Equipment;
  6. Dialysis Machine;
  7. X-Ray Machine; and
  8. Bone marrow cell separator.

Accordingly, as per the said order the importers/manufacturers are required to take import/manufacturing licence from Central Licencing Authority or State Licencing Authority, as the case may be, for import/manufacture of above devices, w.e.f. 1st April, 2021.

In order to ensure  supply chain continuity and access to these Medical Devices, while implementing  smooth transition into the new regulatory regime, Union Ministry of Health and Family Welfare has now decided that in case an existing importer/manufacturer who is already importing /manufacturing any of these devices, has submitted application to Central Licencing Authority or State Licencing Authority, as the case may be, for grant of import /manufacturing licence in respect of the said device(s) under the provisions of MDR, 2017, the said application shall be deemed valid and the importer/manufacturer can continue to import /manufacture the said device(s) up to 6 months from issue of this order or till the time, the Central Licencing Authority or State Licencing Authority, as the case may be, takes a decision on the said application, whichever is earlier. Order in this regard has been issued by Drugs Controller General (India) on 18th April 2021 through CDSCO website.

****

Also See:

newsonline

Recent Posts

Vinpearl Woos Indian Luxury Travelers with Strategic Two-pronged Focus

Vietnam, with its rich cultural heritage and stunning natural beauty, has become an increasingly attractive…

1 day ago

The Bioceramic MoonSwatch MISSION TO EARTHPHASE Celebrates the Splendor of the Earth as Seen from the Moon

The Bioceramic MoonSwatch MISSION TO EARTHPHASE celebrates our two nearest celestial bodies, the Earth and…

2 days ago

Renaissance Global Unveils Renaei: A New Fashion Jewelry Brand Crafted for Gen Z & Millennials

Renaissance Global Limited (RGL), a global leader in branded fine Jewellery, today announced the launch…

2 days ago

Grand Opening of Kalasha Fine Jewels: South India’s Finest Jewellery Store Now Open in Bangalore

Kalasha Fine Jewels showcased the most extravagant and exclusive handcrafted jewellery collection at the store…

2 days ago

Signature Global Hosts its First-Ever Grand Home Fest ‘BOAT’ with Unmatched Diwali Offers

Signature Global, India's leading real estate company, celebrated its first-ever grand home fest, BOAT (Best…

2 days ago

Upgrade Your Smartphone Game with the Best Deals on 5G Phones This Diwali Season

With shoppers gearing up for Diwali festivities, those looking to upgrade their handsets have the…

2 days ago